Subsequent Events	3 Months Ended
Mar. 31, 2014
Subsequent Events [Abstract]
Subsequent Events	11. Subsequent Events Acquisition of BioPharm Systems, Inc. On April 1, 2014, the Company acquired substantially all of the assets of BioPharm Systems, Inc., a California corporation ("California BioPharm"), and all of the outstanding stock of BioPharm Systems, Inc., a Delaware corporation (together with California BioPharm, "BioPharm"), pursuant to the terms of an Asset Purchase Agreement and a Stock Purchase Agreement, for approximately $17.6 million, of which approximately $11.4 million was cash paid at closing and $6.2 million was Company common stock placed in escrow at closing. BioPharm was a business and information technology consulting firm focused on the life sciences industry. The acquisition of BioPharm expands the Company's industry vertical expertise with the addition of a dedicated life sciences vertical. Goodwill and intangible assets are expected to be recorded on the Consolidated Balance Sheet from the acquisition of BioPharm. As of May 8, 2014, the initial accounting for the business combination has not been completed, including the measurement of certain intangible assets and goodwill. Acquisition costs for the three months ended March 31, 2014 were approximately $0.2 million. Acquisition of Trifecta Technologies, Inc. and Trifecta Technologies Canada, Limited On May 7, 2014, the Company acquired substantially all of the assets related to the eCommerce business of Trifecta Technologies, Inc. and Trifecta Technologies Canada, Limited, pursuant to the terms of an Asset Purchase Agreement, for approximately $13.7 million, of which approximately $12.7 million was cash paid at closing and $1.0 million was Company common stock placed in escrow at closing. Trifecta was a business and information technology consulting firm focused on IBM WebSphere Commerce solutions. The acquisition of Trifecta expands our ability to deliver larger, more powerful commerce solutions. Goodwill and intangible assets are expected to be recorded on the Consolidated Balance Sheet from the acquisition of Trifecta. As of May 8, 2014, the initial accounting for the business combination has not been completed, including the measurement of certain intangible assets and goodwill. Acquisition costs for the three months ended March 31, 2014 were immaterial. Amendment to the Credit Agreement The Company and the Lenders entered into Amendment No. 1 to the Second Amended and Restated Credit Agreement (the "Amendment"), pursuant to which the Company and the Lenders increased the amount of available borrowing capacity under the Credit Agreement by $15.0 million, effective as of May 7, 2014, thereby allowing for revolving credit borrowings up to a maximum principal amount of $90.0 million. The Credit Agreement provides for an aggregate commitment increase of up to $25.0 million, including the $15.0 million increase effected by the Amendment.

11. Subsequent Events

Acquisition of BioPharm Systems, Inc.

On April 1, 2014, the Company acquired substantially all of the assets of BioPharm Systems, Inc., a California corporation ("California BioPharm"), and all of the outstanding stock of BioPharm Systems, Inc., a Delaware corporation (together with California BioPharm, "BioPharm"), pursuant to the terms of an Asset Purchase Agreement and a Stock Purchase Agreement, for approximately $17.6 million, of which approximately $11.4 million was cash paid at closing and $6.2 million was Company common stock placed in escrow at closing. BioPharm was a business and information technology consulting firm focused on the life sciences industry. The acquisition of BioPharm expands the Company's industry vertical expertise with the addition of a dedicated life sciences vertical.

Goodwill and intangible assets are expected to be recorded on the Consolidated Balance Sheet from the acquisition of BioPharm. As of May 8, 2014, the initial accounting for the business combination has not been completed, including the measurement of certain intangible assets and goodwill. Acquisition costs for the three months ended March 31, 2014 were approximately $0.2 million.

Acquisition of Trifecta Technologies, Inc. and Trifecta Technologies Canada, Limited

On May 7, 2014, the Company acquired substantially all of the assets related to the eCommerce business of Trifecta Technologies, Inc. and Trifecta Technologies Canada, Limited, pursuant to the terms of an Asset Purchase Agreement, for approximately $13.7 million, of which approximately $12.7 million was cash paid at closing and $1.0 million was Company common stock placed in escrow at closing. Trifecta was a business and information technology consulting firm focused on IBM WebSphere Commerce solutions. The acquisition of Trifecta expands our ability to deliver larger, more powerful commerce solutions.

Goodwill and intangible assets are expected to be recorded on the Consolidated Balance Sheet from the acquisition of Trifecta. As of May 8, 2014, the initial accounting for the business combination has not been completed, including the measurement of certain intangible assets and goodwill. Acquisition costs for the three months ended March 31, 2014 were immaterial.

Amendment to the Credit Agreement

The Company and the Lenders entered into Amendment No. 1 to the Second Amended and Restated Credit Agreement (the "Amendment"), pursuant to which the Company and the Lenders increased the amount of available borrowing capacity under the Credit Agreement by $15.0 million, effective as of May 7, 2014, thereby allowing for revolving credit borrowings up to a maximum principal amount of $90.0 million. The Credit Agreement provides for an aggregate commitment increase of up to $25.0 million, including the $15.0 million increase effected by the Amendment.